List of news related to American Express stock price AXP:

Title: American Express stock hits all-time high at $276.81
URL: https://www.investing.com/news/company-news/american-express-stock-hits-alltime-high-at-27681-93CH-3660458
Time Published: 2024-10-11T18:06:55Z
Full Content:
American Express (NYSE:AXP) shares soared to an all-time high, reaching a price level of $276.81, marking a significant milestone for the financial services giant. This peak comes amidst a robust year for the company, with the stock witnessing an impressive 82.94% surge over the past year. Investors and analysts alike are attributing this exceptional performance to a combination of strategic business moves and a favorable economic environment that has bolstered consumer spending and strengthened the company's core credit card business. The all-time high represents a culmination of sustained growth, reflecting heightened investor confidence in American Express's market position and future prospects. In other recent news, American Express has seen notable developments in its financial performance and corporate governance. The company reported a significant 44% year-over-year earnings growth in the second quarter, marking a record high in revenue and adjusting its full-year earnings per share (EPS) guidance to $13.30 - $13.80. Furthermore, American Express issued $3.4 billion in new debt securities, anticipated to be used for general corporate purposes. In the realm of credit management, American Express disclosed stable U.S. Consumer and Small Business Card Member loan delinquency rates, along with a slight decrease in net write-off rates. The total loans for these segments combined reached $115.1 billion. On the analyst front, JPMorgan downgraded American Express stock from Overweight to Neutral, while RBC Capital Markets maintained an Outperform rating. BMO Capital kept an underperform rating on the company's shares, despite adjusting its near-term earnings forecasts upwards due to lower-than-expected expenses. In terms of corporate governance, American Express amended its bylaws to provide additional clarity on shareholder voting processes. Meanwhile, the Central Bank of Russia revoked the banking license of the company's Russian subsidiary, marking the end of its direct banking presence in the country. These are the recent developments in American Express's operations and financial performance. American Express's recent stock performance aligns with several key financial metrics and analyst observations. According to InvestingPro data, AXP's market capitalization stands at an impressive $196.72 billion, reflecting its significant presence in the financial services sector. The company's P/E ratio of 20.56 suggests a reasonable valuation relative to its earnings, especially considering its strong growth trajectory. InvestingPro Tips highlight AXP's financial strength and market position. The company has maintained dividend payments for 54 consecutive years, demonstrating long-term stability and commitment to shareholder returns. Additionally, AXP is trading near its 52-week high, corroborating the article's mention of the stock reaching an all-time high. The company's revenue growth of 9.62% over the last twelve months and a robust gross profit margin of 55.83% underscore its operational efficiency and ability to capitalize on increased consumer spending. These metrics support the article's assertion of AXP's strong performance in its core credit card business. For investors seeking more comprehensive insights, InvestingPro offers 12 additional tips on American Express, providing a deeper understanding of the company's financial health and market position. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
--------------------------------------------------

Title: 2 No-Brainer Buffett Stocks to Buy Right Now for Less Than $1,000
URL: https://finance.yahoo.com/news/2-no-brainer-buffett-stocks-141500955.html/
Time Published: 2024-10-07T14:15:00Z
Description: These two Buffett stocks are too good to pass up for patient, long-term investors.
--------------------------------------------------